Affiliation:
1. Hematology Laboratory, Mohammed VI University Hospital, Marrakech, Morocco; Faculty of Medicine and Pharmacy of Marrakech, Cadi Ayyad University, Marrakech, Morocco
Abstract
Drug-induced agranulocytosis (DIAG) is a rare but potentially fatal hematological complication. Thiopurines, such as mercaptopurine (6-MP), are widely used in the treatment of chronic inflammatory bowel diseases (IBD), but can cause myelotoxicity due to the accumulation of active metabolites. We report the case of a 48-year-old woman with ulcerative colitis who developed severe agranulocytosis following an accidental overdose of 6-MP. The patient presented with febrile pancytopenia with a neutrophil count of 0.04 G/L. Bone marrow examination revealed normal cellularity with an inversion of the maturation pyramid of the granulocyte lineage. A treatment combining growth factors (filgrastim) and antibiotics (tazobactam) was initiated, leading to progressive improvement over 5 weeks. The toxicity of 6-MP is mainly due to the accumulation of 6-thioguanine nucleotides (6-TGN). The polymorphism of the gene encoding the enzyme thiopurine S-methyltransferase (TPMT) can influence the risk of myelotoxicity. Two strategies are proposed to minimize this risk: evaluation of TPMT activity with dosage adjustment, or regular monitoring of blood counts with gradual dose increase. This case highlights the importance of rigorous biological monitoring when initiating 6-MP treatment, regardless of the TPMT test. Increased vigilance is necessary when using immunosuppressive drugs in the treatment of IBD to optimize efficacy and minimize toxicity.
Reference19 articles.
1. E. Andrès a, F. Maloisel b, le groupe d’étude des agranulocytoses médicamenteuses des Hôpitaux universitaires de Strasbourg: Agranulocytoses médicamenteuses idiosyncrasiques [Idiosyncratic drug-induced agranulocytosis]. La Revue de Médecine Interne. 2006, 27(3): 209-214. https://doi.org/10.1016/j.revmed.2005.06.008
2. Andrès E, Kurtz JE, Maloisel F: Non-chemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature. Clin Lab Haematol. 2002, 24: 99-106. https://doi.org/10.1046/j.1365-2257.2002.00437.x
3. Bénichou C, Solal-Celigny P: Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting. Nouv Rev Fr Hematol. 1991, 33(3): 257-62.
4. David C. Pearson, Gary R. May, Gordon H. Fick, and Lloyd R. Sutherland: Azathioprine and 6- mercaptopurine in Crohn disease. A meta-analysis. Annals of Internal Medicine. 1995, 123(2): 132-142. https://doi.org/10.7326/0003-4819-123-2-199507150-00009
5. S Ardizzone, G Maconi, A Russo, V Imbesi, E Colombo, G Bianchi Porro: Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut. 2006, 55: 47-53. https://doi.org/10.1136/gut.2005.068809